Last edition
News about " Cambrex "
Permira Targets USD 4 Billion Valuation for Cambrex Amid USA Manufacturing Drive
Permira acquired Cambrex in 2019 for approximately USD 2.4 billion. The company now generates about USD 225 million in adjusted annual earnings and operates 14 facilities worldwide, half of which are located in the USA.
Cambrex | 08/09/2025 | By Darshana
Cambrex Expands Snapdragon Chemistry Facility to Boost Peptide Therapy Manufacturing
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the expansion of its Snapdragon Chemistry API facility in Waltham, Massachusetts, strengthening its capabilities in peptide drug development and manufacturing.
Cambrex | 26/08/2025 | By Darshana
Snapdragon Chemistry Expands Massachusetts Facility to Support Peptide Projects
Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts, by adding a new GMP manufacturing suite to strengthen the development and manufacturing of peptide therapies.
Cambrex | 25/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy